Emergent Biosolutions has secured another federal contract, this one
worth as much as $186 million. The company plans to add 25 new jobs at
its Lansing facilities.
According to excerpts from the article:
Emergent said Friday it signed a contract with the U.S. Department of Health and Human Services worth $51 million during the first two years, with options for three more years.
The company has reported plans to manufacture the next-generation [anthrax] vaccine in Maryland, though Adam Havey, president of Emergent's Lansing operations, said the manufacturing site has not been determined.
Development of the vaccine will be carried out in Maryland and Lansing, he said.
The company employs more than 400 in Lansing, up from nearly 340 at the end of 2008.
Read the entire article
here.
Enjoy this story?
Sign up for free solutions-based reporting in your inbox each week.